Lv6
2044 积分 2024-08-07 加入
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies
14小时前
待确认
Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma
3天前
已完结
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
3天前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
3天前
已完结
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial
4天前
已完结
Real-World Safety Profile of Ibrutinib in Chronic Lymphocytic Leukemia: A Focus on Adverse Events, Discontinuations, and Effectiveness Outcomes
5天前
已完结
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis
11天前
已完结
Hormone Receptor Status as a Predictive Factor for Pathological Complete Response to Neoadjuvant Dual HER2 Blockade in Patients with HER2-Positive Breast Cancer: A Multicenter Retrospective Study
11天前
已完结
Does Surgical Timing After Neoadjuvant Anti‐HER2 Therapy Affect Pathological Complete Response and Survival in HER2‐Positive Breast Cancer? A Multicenter Retrospective Cohort Study
11天前
已关闭
Economic Evaluation and Budget Impact of Biosimilar Trastuzumab for HER2-Positive Metastatic Breast Cancer in Thailand: Policy Implications for Access and Affordability
11天前
已关闭
急性骨筋膜室综合征早期诊断与治疗指南
10个月前
已采纳
针灸改善子宫内膜容受性有效性Meta分析
10个月前
已采纳
巨噬细胞炎症因子-1β在胶原诱导关节炎中的表达及其意义
10个月前
已采纳
成人非囊性纤维化性支气管扩张的诊治进展
10个月前
已采纳
脾脏血管肉瘤伴肝脏多发转移一例
10个月前
已采纳
皖公网安备34019202002308
